Panacea Life Sciences Holdings, Inc.
Panacea Life Sciences Holdings, Inc. (PLSH) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · PLSH · as of Jun 15, 2026
Activity summary
Buy transactions
17
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Panacea Life Sciences Holdings, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 15, 2026
PLSH insider buying and selling by quarter
PLSH insider selling · PLSH insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 15, 2026
Recent insider transactions
PLSH executive sell shares · PLSH board member insider trading · PLSH insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 18, 2023 | Buttorff Leslie CEO · Director | Purchase | 20,000 | $5K | Form 4 |
| Jun 9, 2023 | Buttorff Leslie CEO · Director | Purchase | 3,000 | $1K | Form 4 |
| Jun 2, 2023 | Buttorff Leslie CEO · Director | Award | 760,000 | $380K | Form 4 |
| May 23, 2023 | Buttorff Leslie CEO · Director | Purchase | 500 | $249 | Form 4 |
| May 19, 2023 | Buttorff Leslie CEO · Director | Purchase | 1,500 | $780 | Form 4 |
| May 19, 2023 | Buttorff Leslie CEO · Director | Purchase | 4,500 | $2K | Form 4 |
| May 9, 2023 | Buttorff Leslie CEO · Director | Purchase | 2,300 | $867 | Form 4 |
| May 8, 2023 | Buttorff Leslie CEO · Director | Purchase | 1,500 | $645 | Form 4 |
| May 5, 2023 | Buttorff Leslie CEO · Director | Purchase | 11,500 | $6K | Form 4 |
| Apr 26, 2023 | Buttorff Leslie CEO · Director | Purchase | 5,500 | $2K | Form 4 |
| Apr 25, 2023 | Buttorff Leslie CEO · Director | Purchase | 3,500 | $1K | Form 4 |
| Apr 25, 2023 | Buttorff Leslie CEO · Director | Purchase | 1,000 | $320 | Form 4 |
| Apr 5, 2023 | Buttorff Leslie CEO · Director | Purchase | 2,500 | $825 | Form 4 |
| Apr 4, 2023 | Buttorff Leslie CEO · Director | Purchase | 3,200 | $1K | Form 4 |
| Apr 3, 2023 | Buttorff Leslie CEO · Director | Purchase | 1,000 | $360 | Form 4 |
| Feb 27, 2023 | Buttorff Leslie CEO · Director | Purchase | 1,000 | $190 | Form 4 |
| Feb 27, 2023 | Buttorff Leslie CEO · Director | Purchase | 2,000 | $345 | Form 4 |
| Feb 26, 2023 | Buttorff Leslie CEO · Director | Purchase | 1,000 | $190 | Form 4 |
| Aug 26, 2022 | Buttorff Leslie CEO | Purchase | 11,500 | $2K | Form 4 |
| Aug 11, 2022 | Wert Lawrence Director | Purchase | 5,000 | $640 | Form 4 |
| Aug 3, 2022 | Buttorff Leslie CEO | Purchase | 2,600 | $260 | Form 4 |
| Jul 8, 2022 | Buttorff Leslie CEO | Purchase | 2,100 | $836 | Form 4 |
| Apr 4, 2022 | Buttorff Leslie CEO | Purchase | 1,404 | $842 | Form 4 |
| Jun 30, 2021 | Berman Nathan Joel CONTROLLER & PRIN ACTNG OFCR | Award | 496,957 | — | Form 4 |
| Jun 30, 2021 | Buttorff Leslie CHIEF EXECUTIVE OFFICER · Director | Award | 318,317,499 | — | Form 4 |
Berman Nathan Joel
CONTROLLER & PRIN ACTNG OFCR
Date
Jun 30
Shares
496,957
Price
—
Value
—
Buttorff Leslie
CHIEF EXECUTIVE OFFICER · Director
Date
Jun 30
Shares
318,317,499
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About PLSH insider trading
PLSH insider trades
Panacea Life Sciences Holdings, Inc. (PLSH) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including PLSH. Over the past 12 months, 0 insiders have filed transactions with the SEC. PLSH insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Panacea Life Sciences Holdings, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
PLSH insider trading · 5 questionsThe insiders of Panacea Life Sciences Holdings, Inc. (PLSH) include executives and directors such as PLSH, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 15, 2026